Lantern Pharma announces public demonstration of withZeta.ai

Lantern Pharma (LTRN) announced the first public demonstration of withZeta.ai, its multi-agentic AI co-scientist platform, to be held on Thursday, April 30, 2026. The event follows the platform’s scientific community debut at the American Association for Cancer Research Annual Meeting 2026 and its initial unveiling at Nasdaq MarketSite – and marks the first time the platform will be demonstrated live and without restriction to a global public audience of investors, researchers, and industry participants. Attendees will watch in real time as the platform executes complex research workflows – synthesizing clinical, molecular, and scientific datasets simultaneously to generate insights and compress research timelines that historically required months of manual effort. This is not a product marketing event. It is a transparency event, and the platform will speak for itself.